Question to the Department for Environment, Food and Rural Affairs:

To ask His Majesty's Government what plans, if any, they have to change the classification of spot-on pet treatments containing fipronil and imidacloprid from the current general sales (AVM-GS) to the prescription only (POM-V) classification.

Spot‑on flea and tick treatments containing fipronil and imidacloprid remain important for protecting animal and human health. Many of these products are currently classified as AVM‑GSL, meaning they may be supplied without professional advice. The Veterinary Medicines Directorate (VMD) recognises increasing concerns about the environmental presence of these substances, which have been detected in some UK watercourses at levels above toxicity thresholds for aquatic invertebrates.

The VMD is carrying out a regulatory review of the AVM‑GSL status of products containing fipronil and imidacloprid. Further details on this review will be made available early this year. The review will assess whether requiring professional advice at the point of sale, such as through a minimum NFA‑VPS classification, could support more responsible use and disposal.

The regulatory review will consider all legal distribution channels with any future decisions being transparent, evidence‑based and to maintain animal welfare and access to treatment.